Remove Leads Remove Safety Remove Side effects Remove Transportation
article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

article thumbnail

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

Compromising on quality might save a few bucks initially but can lead to a tattered, unprofessional look that does more harm than good in the long run. A chaotic bag can lead to a chaotic presentation. Ease of Transport: Comfort and Convenience Sales reps are often on the move, so ease of transport is a critical feature.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Two Key Questions About Adherence/Compliance in 2022

PM360

Accordingly, multiple reasons for subpar patient adherence are gaining attention, including fear of side effects, lack of medical understanding, or even financial limitations. Housing, access to food and transportation, as well as the ability to pay for healthcare and medicine are just a few economic barriers to medical adherence.

Medical 105
article thumbnail

Top 5 Emerging Trends in Pharma Industry

Medico Reach

AI can lead to faster research, combining and extracting data into usable formats, making clinical trials more efficient and saving time. Blockchain simplifies the tracing actions, thus ensuring secure transportation of fragile and sensitive APIs and other raw materials. The global pharmacovigilance (PV) market stood at USD 7.80

Pharma 52
article thumbnail

Can the FDA keep the momentum going for rare disease drug approvals?

Pharmaceutical Technology

The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities. DMD pathology is caused by a lack of dystrophin protein, leading to the weakening and damage of muscle cells progressively over time. In clinical trials, the drug showed a 3.8-point

FDA 126